| __timestamp | Novartis AG | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 9086000000 | 1488000000 |
| Thursday, January 1, 2015 | 8935000000 | 1525000000 |
| Friday, January 1, 2016 | 9039000000 | 2111000000 |
| Sunday, January 1, 2017 | 8972000000 | 1848000000 |
| Monday, January 1, 2018 | 9074000000 | 1213000000 |
| Tuesday, January 1, 2019 | 9402000000 | 1010000000 |
| Wednesday, January 1, 2020 | 8980000000 | 997000000 |
| Friday, January 1, 2021 | 9540000000 | 967000000 |
| Saturday, January 1, 2022 | 9996000000 | 838000000 |
| Sunday, January 1, 2023 | 11371000000 | 953000000 |
| Monday, January 1, 2024 | 10022000000 | 998000000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, innovation is key. Over the past decade, Novartis AG and Teva Pharmaceutical Industries Limited have demonstrated contrasting approaches to research and development (R&D) spending. From 2014 to 2023, Novartis consistently invested heavily in R&D, with a notable 26% increase in spending, peaking at approximately $11.4 billion in 2023. This commitment underscores Novartis's strategy to maintain its leadership in drug innovation.
Conversely, Teva's R&D expenditure has seen a downward trend, decreasing by about 36% over the same period. In 2023, Teva's R&D spending was just under $1 billion, reflecting a strategic shift towards cost optimization amidst financial challenges. This divergence in R&D investment highlights the different paths these companies are taking in the ever-evolving pharmaceutical landscape, with Novartis focusing on innovation and Teva on financial restructuring.
Research and Development Expenses Breakdown: Novo Nordisk A/S vs Novartis AG
Novo Nordisk A/S or Teva Pharmaceutical Industries Limited: Who Invests More in Innovation?
Analyzing R&D Budgets: Novartis AG vs Bristol-Myers Squibb Company
R&D Insights: How Novartis AG and Exelixis, Inc. Allocate Funds
Analyzing R&D Budgets: Novartis AG vs Amneal Pharmaceuticals, Inc.
R&D Insights: How Novartis AG and MannKind Corporation Allocate Funds
R&D Insights: How Teva Pharmaceutical Industries Limited and Neurocrine Biosciences, Inc. Allocate Funds
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Corcept Therapeutics Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Viking Therapeutics, Inc.
R&D Insights: How Teva Pharmaceutical Industries Limited and Protagonist Therapeutics, Inc. Allocate Funds
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Teva Pharmaceutical Industries Limited vs MannKind Corporation: Strategic Focus on R&D Spending